Dispatch Bio has dosed the first participant in a Phase I clinical trial evaluating the safety and efficacy of DISP-10 in adult participants with advanced gastrointestinal (GI) cancers, including colorectal cancer, gastric adenocarcinoma, oesophageal adenocarcinoma, and gastroesophageal adenocarcinoma. The participant was treated with both DV-10 and ide-cel… Read More
People who show signs of faster biological ageing could be more likely to develop cancer earlier in life, a new study suggests. Scientists from the PROSPECT team, funded by Cancer Grand Challenges, analysed blood samples and health information from more than 164,000 people from the UK and… Read More
In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. In this episode, Megan Thomas is in conversation with Dr Emil Lou,… Read More
